menu
    • menu

    Company profile for Nightstar Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Nightstar, our mission is to maintain and restore sight in patients with inherited retinal diseases. We are a clinical-stage company focused on developing and commercializing a pipeline of novel and potentially curative, one-time retinal gene therapies for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness, and, for which, there are no currently approved treatments.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nightstar Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    10 Midford Place London W1T 5BJ
    Telephone
    Telephone
    +44 (0)20 7062 2777
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nightstartx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Edging toward a pivotal readout, Biogen picks a new discovery partner
    Edging toward a pivotal readout, Biogen picks a new discovery partner

    05 Jan 2021

    // Amber Tong ENDPTS

    https://endpts.com/edging-toward-a-pivotal-readout-biogen-picks-a-new-discovery-partner-for-ophthalmic-gene-therapy/

    Amber Tong ENDPTS
    05 Jan 2021
    Share Share
    Who's the next Big Pharma takeout target? Biogen, uniQure, AZ top the list
    Who's the next Big Pharma takeout target? Biogen, uniQure, AZ top the list

    26 Jun 2019

    // Arlene Weintraub FIERCE PHARMA

    https://www.fiercepharma.com/pharma/what-s-next-big-biopharma-m-a-target-uniqure-biogen-and-more-report

    Arlene Weintraub FIERCE PHARMA
    26 Jun 2019
    Share Share
    UniQure weighs sale after hemophilia gene therapy turnaround
    UniQure weighs sale after hemophilia gene therapy turnaround

    17 Jun 2019

    // Nick P. Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/uniqure-weighs-sale-after-hemophilia-gene-therapy-turnaround-report

    Nick P. Taylor FIERCE BIOTECH
    17 Jun 2019
    Share Share
    Nightstar Therapeutics Announcement of Expiry of HSR Waiting Period
    Nightstar Therapeutics Announcement of Expiry of HSR Waiting Period

    16 Apr 2019

    // GLOBENEWIRE

    https://www.globenewswire.com/news-release/2019/04/16/1804751/0/en/Nightstar-Therapeutics-plc-Announcement-of-Expiry-of-HSR-Waiting-Period-and-Satisfaction-of-Antitrust-Condition.html

    GLOBENEWIRE
    16 Apr 2019
    Share Share
    Pharmacquired: Biogen could use a big deal
    Pharmacquired: Biogen could use a big deal

    22 Mar 2019

    // Jacob Bell BIOPHARMA DIVE

    https://www.biopharmadive.com/news/pharmacquired-biogen-could-use-a-big-deal-too-bad-it-doesnt-do-those/551058/

    Jacob Bell BIOPHARMA DIVE
    22 Mar 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search